JPS5144499B1
(ru)
|
1970-08-29 |
1976-11-29 |
|
|
JPS5334319B2
(ru)
|
1971-12-28 |
1978-09-20 |
|
|
JPS5616428B2
(ru)
|
1973-04-13 |
1981-04-16 |
|
|
JPS6048972B2
(ja)
|
1975-08-08 |
1985-10-30 |
株式会社日立製作所 |
方向比較搬送保護継電装置
|
JPS5816170B2
(ja)
|
1977-03-16 |
1983-03-30 |
旭化成株式会社 |
乾式画像形成材料
|
US4208479A
(en)
|
1977-07-14 |
1980-06-17 |
Syva Company |
Label modified immunoassays
|
JPS5970B2
(ja)
|
1978-02-10 |
1984-01-05 |
エプソン株式会社 |
小型プリンタの紙送り機構
|
JPS55134615A
(en)
|
1979-04-05 |
1980-10-20 |
Ishigaki Kiko Kk |
Removing device for cake in filter press
|
JPS5912436B2
(ja)
|
1980-08-05 |
1984-03-23 |
ファナック株式会社 |
工業用ロボットの安全機構
|
JPS6022444B2
(ja)
|
1980-11-08 |
1985-06-01 |
日立化成工業株式会社 |
集成マイカ材料,集成マイカプリプレグ材料及び集成マイカ製品
|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
US4444878A
(en)
|
1981-12-21 |
1984-04-24 |
Boston Biomedical Research Institute, Inc. |
Bispecific antibody determinants
|
JPS58201994A
(ja)
|
1982-05-21 |
1983-11-25 |
Hideaki Hagiwara |
抗原特異的ヒト免疫グロブリンの生産方法
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
AU600575B2
(en)
|
1987-03-18 |
1990-08-16 |
Sb2, Inc. |
Altered antibodies
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
US5322678A
(en)
|
1988-02-17 |
1994-06-21 |
Neorx Corporation |
Alteration of pharmacokinetics of proteins by charge modification
|
US6010902A
(en)
|
1988-04-04 |
2000-01-04 |
Bristol-Meyers Squibb Company |
Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
|
IL89491A0
(en)
|
1988-11-17 |
1989-09-10 |
Hybritech Inc |
Bifunctional chimeric antibodies
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
ATE177321T1
(de)
|
1989-12-11 |
1999-03-15 |
Immunomedics Inc |
Verfahren zum aufspüren von diagnostischen oder therapeutischen mitteln durch antikörper
|
TW212184B
(ru)
|
1990-04-02 |
1993-09-01 |
Takeda Pharm Industry Co Ltd |
|
JPH04228089A
(ja)
|
1990-05-15 |
1992-08-18 |
Kanegafuchi Chem Ind Co Ltd |
高カルシウム血症治療・予防剤
|
JPH05184383A
(ja)
|
1990-06-19 |
1993-07-27 |
Dainabotsuto Kk |
二重特異性抗体
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
CA2109602C
(en)
|
1990-07-10 |
2002-10-01 |
Gregory P. Winter |
Methods for producing members of specific binding pairs
|
JPH05199894A
(ja)
|
1990-08-20 |
1993-08-10 |
Takeda Chem Ind Ltd |
二重特異性抗体および抗体含有薬剤
|
EP0814159B1
(en)
|
1990-08-29 |
2005-07-27 |
GenPharm International, Inc. |
Transgenic mice capable of producing heterologous antibodies
|
ES2134212T3
(es)
|
1991-04-25 |
1999-10-01 |
Chugai Pharmaceutical Co Ltd |
Anticuerpo humano reconstituido contra el receptor de la interleuquina 6 humano.
|
JPH04336051A
(ja)
|
1991-05-10 |
1992-11-24 |
Toshiba Corp |
超音波診断装置
|
JPH05304992A
(ja)
|
1991-06-20 |
1993-11-19 |
Takeda Chem Ind Ltd |
ハイブリッド・モノクローナル抗体および抗体含有薬剤
|
EP0605522B1
(en)
|
1991-09-23 |
1999-06-23 |
Medical Research Council |
Methods for the production of humanized antibodies
|
US6027725A
(en)
|
1991-11-25 |
2000-02-22 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
ES2165851T3
(es)
|
1991-11-25 |
2002-04-01 |
Enzon Inc |
Proteinas multivalentes que se unen a antigenos.
|
ATE463573T1
(de)
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
AU3328493A
(en)
|
1991-12-17 |
1993-07-19 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5667988A
(en)
|
1992-01-27 |
1997-09-16 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
JPH05203652A
(ja)
|
1992-01-28 |
1993-08-10 |
Fuji Photo Film Co Ltd |
抗体酵素免疫分析法
|
JPH05213775A
(ja)
|
1992-02-05 |
1993-08-24 |
Otsuka Pharmaceut Co Ltd |
Bfa抗体
|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
JP3507073B2
(ja)
|
1992-03-24 |
2004-03-15 |
ケンブリッジ アンティボディー テクノロジー リミティド |
特異的結合対の成員の製造方法
|
US6129914A
(en)
|
1992-03-27 |
2000-10-10 |
Protein Design Labs, Inc. |
Bispecific antibody effective to treat B-cell lymphoma and cell line
|
US5744446A
(en)
|
1992-04-07 |
1998-04-28 |
Emory University |
Hybrid human/animal factor VIII
|
EP0640094A1
(en)
|
1992-04-24 |
1995-03-01 |
The Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
NZ255101A
(en)
|
1992-07-24 |
1997-08-22 |
Cell Genesys Inc |
A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
|
ZA936260B
(en)
|
1992-09-09 |
1994-03-18 |
Smithkline Beecham Corp |
Novel antibodies for conferring passive immunity against infection by a pathogen in man
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
GB9313509D0
(en)
|
1993-06-30 |
1993-08-11 |
Medical Res Council |
Chemisynthetic libraries
|
WO1995014041A1
(fr)
|
1993-11-19 |
1995-05-26 |
Chugai Seiyaku Kabushiki Kaisha |
Anticorps humain reconstitue contre des cellules medulloblastomateuses humaines
|
WO1995015388A1
(en)
|
1993-12-03 |
1995-06-08 |
Medical Research Council |
Recombinant binding proteins and peptides
|
US6214613B1
(en)
|
1993-12-03 |
2001-04-10 |
Ashai Kasei Kogyo Kabushiki Kaisha |
Expression screening vector
|
JP3485266B2
(ja)
|
1994-05-20 |
2004-01-13 |
松下電器産業株式会社 |
プロセッサ
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
DE69535243T2
(de)
|
1994-07-13 |
2007-05-10 |
Chugai Seiyaku K.K. |
Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
|
AU3272695A
(en)
|
1994-08-12 |
1996-03-07 |
Immunomedics Inc. |
Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
|
US6309636B1
(en)
|
1995-09-14 |
2001-10-30 |
Cancer Research Institute Of Contra Costa |
Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
|
EP2077120A3
(en)
|
1994-10-07 |
2009-07-15 |
Chugai Seiyaku Kabushiki Kaisha |
Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient
|
HU227708B1
(en)
|
1994-10-21 |
2011-12-28 |
Chugai Pharmaceutical Co Ltd |
Use of anti-interleukin-6-receptor antibodies mr-16 and pm-1 and derivatives thereof for producing pharmaceutical preparation for treating diseases caused by il-6 production
|
EP1241264A1
(en)
|
1994-12-02 |
2002-09-18 |
Chiron Corporation |
Monoclonal antibodies to colon cancer antigen
|
US6485943B2
(en)
|
1995-01-17 |
2002-11-26 |
The University Of Chicago |
Method for altering antibody light chain interactions
|
BR9604884A
(pt)
|
1995-02-28 |
1998-05-19 |
Procter & Gamble |
Preparação de produtos de bebida não carbonatada com estabilidade microbiana superior
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
JP4312259B2
(ja)
|
1995-04-27 |
2009-08-12 |
アムジェン フレモント インク. |
免疫したゼノマウス(XenoMouse)に由来するヒト抗体
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
KR100259828B1
(ko)
|
1995-09-11 |
2000-06-15 |
히라타 다다시 |
인체 인터루킨 5 수용체 알파-사슬에 대한 항체
|
MA24512A1
(fr)
|
1996-01-17 |
1998-12-31 |
Univ Vermont And State Agrienl |
Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
|
EP0938499A1
(en)
|
1996-07-19 |
1999-09-01 |
Amgen Inc. |
Analogs of cationic proteins
|
RU2198220C2
(ru)
|
1996-09-26 |
2003-02-10 |
Чугаи Сейяку Кабусики Кайся |
Антитело против белка, родственного паращитовидному гормону человека, днк, вектор, способ получения и использование антитела
|
JP3587664B2
(ja)
|
1996-10-04 |
2004-11-10 |
中外製薬株式会社 |
再構成ヒト抗hm1.24抗体
|
UA76934C2
(en)
|
1996-10-04 |
2006-10-16 |
Chugai Pharmaceutical Co Ltd |
Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody
|
WO1998023289A1
(en)
|
1996-11-27 |
1998-06-04 |
The General Hospital Corporation |
MODULATION OF IgG BINDING TO FcRn
|
JPH10165184A
(ja)
|
1996-12-16 |
1998-06-23 |
Tosoh Corp |
抗体、遺伝子及びキメラ抗体の製法
|
US5990286A
(en)
|
1996-12-18 |
1999-11-23 |
Techniclone, Inc. |
Antibodies with reduced net positive charge
|
JPH10256223A
(ja)
|
1997-03-11 |
1998-09-25 |
Super Silicon Kenkyusho:Kk |
ウェーハ面取り部の枚葉処理装置
|
JP4228089B2
(ja)
|
1997-03-11 |
2009-02-25 |
株式会社ニコン |
過電流検知機構およびそれを用いた電子閃光装置
|
US20070059302A1
(en)
|
1997-04-07 |
2007-03-15 |
Genentech, Inc. |
Anti-vegf antibodies
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
FR2761994B1
(fr)
|
1997-04-11 |
1999-06-18 |
Centre Nat Rech Scient |
Preparation de recepteurs membranaires a partir de baculovirus extracellulaires
|
DE69830901T2
(de)
|
1997-05-02 |
2006-05-24 |
Genentech Inc., San Francisco |
ein verfahren zur herstellung multispezifischer antikörper die heteromultimere und gemeinsame komponenten besitzen
|
US20020062010A1
(en)
|
1997-05-02 |
2002-05-23 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
US20030207346A1
(en)
|
1997-05-02 |
2003-11-06 |
William R. Arathoon |
Method for making multispecific antibodies having heteromultimeric and common components
|
DE19725586C2
(de)
|
1997-06-17 |
1999-06-24 |
Gsf Forschungszentrum Umwelt |
Verfahren zur Herstellung von Zellpräparaten zur Immunisierung mittels heterologer intakter bispezifischer und/oder trispezifischer Antikörper
|
US6207805B1
(en)
|
1997-07-18 |
2001-03-27 |
University Of Iowa Research Foundation |
Prostate cell surface antigen-specific antibodies
|
US6617156B1
(en)
|
1997-08-15 |
2003-09-09 |
Lynn A. Doucette-Stamm |
Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
US7361336B1
(en)
|
1997-09-18 |
2008-04-22 |
Ivan Bergstein |
Methods of cancer therapy targeted against a cancer stem line
|
WO1999018212A1
(fr)
|
1997-10-03 |
1999-04-15 |
Chugai Seiyaku Kabushiki Kaisha |
Anticorps humain naturel
|
JPH11118775A
(ja)
|
1997-10-09 |
1999-04-30 |
Canon Inc |
超音波検査装置
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
PL343322A1
(en)
|
1998-04-03 |
2001-08-13 |
Chugai Pharmaceutical Co Ltd |
Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody
|
EP2180007B2
(en)
|
1998-04-20 |
2017-08-30 |
Roche Glycart AG |
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
JP3445153B2
(ja)
|
1998-06-04 |
2003-09-08 |
富士通株式会社 |
電話番号一時的使用装置及び方法
|
WO2000009560A2
(en)
|
1998-08-17 |
2000-02-24 |
Abgenix, Inc. |
Generation of modified molecules with increased serum half-lives
|
WO2000018806A1
(de)
|
1998-09-25 |
2000-04-06 |
Horst Lindhofer |
Bispezifische und trispezifische antikörper, die spezifisch mit induzierbaren oberflächenantigenen als operationelle zielstrukturen reagieren
|
CA2346264A1
(en)
|
1998-10-16 |
2000-04-27 |
Regents Of The University Of California |
Glypicans for the detection and treatment of human carcinoma
|
US6329511B1
(en)
|
1998-12-01 |
2001-12-11 |
Protein Design Labs, Inc. |
Humanized antibodies to γ-interferon
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
MXPA01007170A
(es)
|
1999-01-15 |
2002-07-30 |
Genentech Inc |
Variantes de polipeptidos con funcion efectora alterada.
|
US7183387B1
(en)
|
1999-01-15 |
2007-02-27 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
WO2000047228A1
(en)
|
1999-02-12 |
2000-08-17 |
The Scripps Research Institute |
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
|
US6972125B2
(en)
|
1999-02-12 |
2005-12-06 |
Genetics Institute, Llc |
Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
|
EP2275540B1
(en)
|
1999-04-09 |
2016-03-23 |
Kyowa Hakko Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
WO2004009618A2
(en)
|
2002-07-18 |
2004-01-29 |
Crucell Holland B.V. |
Recombinant production of mixtures of antibodies
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
TWI248365B
(en)
|
1999-08-23 |
2006-02-01 |
Chugai Pharmaceutical Co Ltd |
HM1.24 antigen expression potentiators
|
AT411997B
(de)
|
1999-09-14 |
2004-08-26 |
Baxter Ag |
Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
|
JP3606132B2
(ja)
|
1999-10-14 |
2005-01-05 |
Jfeエンジニアリング株式会社 |
超音波探傷方法およびその装置
|
SE9903895D0
(sv)
|
1999-10-28 |
1999-10-28 |
Active Biotech Ab |
Novel compounds
|
AU6627201A
(en)
|
2000-05-03 |
2001-11-12 |
Mbt Munich Biotechnology Gmbh |
Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
|
JP2004511430A
(ja)
|
2000-05-24 |
2004-04-15 |
イムクローン システムズ インコーポレイティド |
二重特異性免疫グロブリン様抗原結合蛋白および製造方法
|
GB0017635D0
(en)
|
2000-07-18 |
2000-09-06 |
Pharmacia & Upjohn Spa |
Antitumor combined therapy
|
JP2002048867A
(ja)
|
2000-08-07 |
2002-02-15 |
Mitsubishi Heavy Ind Ltd |
音響探査装置
|
MXPA03002161A
(es)
|
2000-09-12 |
2006-03-21 |
Union Carbide Chem Plastic |
Compuestos de polimeros que contienen copolimeros de oxido de alquileno.
|
CA2785941C
(en)
|
2000-10-06 |
2017-01-10 |
Kyowa Hakko Kirin Co., Ltd. |
Antibody composition-producing cell
|
US7521054B2
(en)
|
2000-11-17 |
2009-04-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric point
|
US7361343B2
(en)
|
2003-01-21 |
2008-04-22 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
JP4336498B2
(ja)
|
2000-12-12 |
2009-09-30 |
メディミューン,エルエルシー |
延長した半減期を有する分子ならびにその組成物および用途
|
US20030003097A1
(en)
|
2001-04-02 |
2003-01-02 |
Idec Pharmaceutical Corporation |
Recombinant antibodies coexpressed with GnTIII
|
CN1294148C
(zh)
|
2001-04-11 |
2007-01-10 |
中国科学院遗传与发育生物学研究所 |
环状单链三特异抗体
|
EP1250023A1
(en)
|
2001-04-11 |
2002-10-16 |
Alcatel |
Provision of subscriber QoS guarantees to roaming subscribers
|
DE60236735D1
(de)
|
2001-04-13 |
2010-07-29 |
Biogen Idec Inc |
Antikörper gegen vla-1
|
JP3642316B2
(ja)
|
2001-06-15 |
2005-04-27 |
日本電気株式会社 |
化学増幅レジスト用単量体、化学増幅レジスト用重合体、化学増幅レジスト組成物、パターン形成方法
|
AU2002315857B2
(en)
|
2001-06-22 |
2007-07-26 |
Kaisha, Chugai Seiyaku Kabushiki |
Cell proliferation inhibitors containing anti-glypican 3 antibody
|
DE10136273A1
(de)
|
2001-07-25 |
2003-02-13 |
Sabine Debuschewitz |
Molekulare Marker beim hepatozellulären Karzinom
|
IL160170A0
(en)
|
2001-08-03 |
2004-07-25 |
Glycart Biotechnology Ag |
A host cell engineered to produce a polypeptide having increased cytotoxicity
|
US20030049203A1
(en)
|
2001-08-31 |
2003-03-13 |
Elmaleh David R. |
Targeted nucleic acid constructs and uses related thereto
|
DE60216305T2
(de)
|
2001-10-03 |
2007-07-05 |
Celator Pharmaceuticals, Inc. |
Zusammensetzungen und Verfahren zur Abgabe von Arzneimittelkombinationen
|
US7850990B2
(en)
|
2001-10-03 |
2010-12-14 |
Celator Pharmaceuticals, Inc. |
Compositions for delivery of drug combinations
|
JP2005532253A
(ja)
|
2001-10-25 |
2005-10-27 |
ジェネンテック・インコーポレーテッド |
糖タンパク質組成物
|
DE10156482A1
(de)
|
2001-11-12 |
2003-05-28 |
Gundram Jung |
Bispezifisches Antikörper-Molekül
|
JP4087098B2
(ja)
|
2001-11-14 |
2008-05-14 |
株式会社東芝 |
超音波検査装置
|
JP3961359B2
(ja)
|
2002-07-18 |
2007-08-22 |
株式会社東芝 |
超音波画像化装置
|
KR100559808B1
(ko)
|
2001-11-14 |
2006-03-15 |
가부시끼가이샤 도시바 |
검사 장치 및 초음파 검사 장치
|
JP2003157075A
(ja)
|
2001-11-22 |
2003-05-30 |
Kawai Musical Instr Mfg Co Ltd |
電子楽器のパラメータ入力装置
|
AU2002362197A1
(en)
|
2001-12-28 |
2003-07-24 |
Chugai Seiyaku Kabushiki Kaisha |
Method of stabilizing protein
|
BR0307548A
(pt)
|
2002-02-11 |
2006-01-17 |
Genentech Inc |
Método de produção de uma variante de anticorpo, variante de anticorpo, composição, ácido nucléico isolado, vetor, célula hospedeira, processo para a produção de uma variante de anticorpo e método de determinação do coeficiente de associação de antìgeno de um anticorpo
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
US8188231B2
(en)
|
2002-09-27 |
2012-05-29 |
Xencor, Inc. |
Optimized FC variants
|
US7662925B2
(en)
|
2002-03-01 |
2010-02-16 |
Xencor, Inc. |
Optimized Fc variants and methods for their generation
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
AU2003217912A1
(en)
|
2002-03-01 |
2003-09-16 |
Xencor |
Antibody optimization
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
US20040259150A1
(en)
|
2002-04-09 |
2004-12-23 |
Kyowa Hakko Kogyo Co., Ltd. |
Method of enhancing of binding activity of antibody composition to Fcgamma receptor IIIa
|
WO2003087163A1
(fr)
|
2002-04-15 |
2003-10-23 |
Chugai Seiyaku Kabushiki Kaisha |
Procede d'elaboration d'une banque scdb
|
JP4518941B2
(ja)
|
2002-04-26 |
2010-08-04 |
中外製薬株式会社 |
アゴニスト抗体のスクリーニング方法
|
US7883853B2
(en)
|
2002-05-23 |
2011-02-08 |
Sunnybrook Health Sciences Centre |
Diagnosis of hepatocellular carcinoma
|
US20060088899A1
(en)
|
2002-05-31 |
2006-04-27 |
Alvarez Vernon L |
Combination chemotherapy with chlorotoxin
|
JP2004086862A
(ja)
|
2002-05-31 |
2004-03-18 |
Celestar Lexico-Sciences Inc |
タンパク質相互作用情報処理装置、タンパク質相互作用情報処理方法、プログラム、および、記録媒体
|
WO2003107218A1
(ja)
|
2002-05-31 |
2003-12-24 |
セレスター・レキシコ・サイエンシズ株式会社 |
相互作用予測装置
|
EP1600459A3
(en)
|
2002-06-28 |
2005-12-07 |
Domantis Limited |
Ligand
|
WO2004016740A2
(en)
|
2002-08-15 |
2004-02-26 |
Epitomics, Inc. |
Humanized rabbit antibodies
|
AU2003254950A1
(en)
|
2002-08-26 |
2004-03-11 |
Kirin Beer Kabushiki Kaisha |
Peptides and drugs containing the same
|
AU2002328429A1
(en)
|
2002-09-04 |
2004-03-29 |
Chugai Seiyaku Kabushiki Kaisha |
CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE
|
AU2002338020A1
(en)
|
2002-09-04 |
2004-03-29 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody against blood-solubilized n-terminal peptide in gpc3
|
AU2002330482A1
(en)
|
2002-09-04 |
2004-03-29 |
Perseus Proteomics Inc. |
Method of diagnosing cancer by detecting gpc3
|
US20060235208A1
(en)
|
2002-09-27 |
2006-10-19 |
Xencor, Inc. |
Fc variants with optimized properties
|
EP2345671B8
(en)
|
2002-09-27 |
2023-01-11 |
Xencor, Inc. |
Optimized fc variants and methods for their generation
|
AU2003286467B2
(en)
|
2002-10-15 |
2009-10-01 |
Abbvie Biotherapeutics Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
DK3284753T3
(da)
|
2002-10-17 |
2021-07-05 |
Genmab As |
Humane monoklonale antistoffer mod cd20 til anvendelse i behandlingen af multipel sclerose
|
JP4477579B2
(ja)
*
|
2003-01-21 |
2010-06-09 |
中外製薬株式会社 |
抗体の軽鎖スクリーニング方法
|
JP2006517109A
(ja)
|
2003-02-07 |
2006-07-20 |
プロテイン デザイン ラブス インコーポレイテッド |
アンフィレグリン抗体ならびに癌および乾癬を処置するためのその使用
|
US8388955B2
(en)
|
2003-03-03 |
2013-03-05 |
Xencor, Inc. |
Fc variants
|
US20090010920A1
(en)
|
2003-03-03 |
2009-01-08 |
Xencor, Inc. |
Fc Variants Having Decreased Affinity for FcyRIIb
|
US20060228694A1
(en)
|
2003-04-02 |
2006-10-12 |
Janoff Andrew S |
Methods to individualize combination therapy
|
GB2400851B
(en)
|
2003-04-25 |
2004-12-15 |
Bioinvent Int Ab |
Identifying binding of a polypeptide to a polypeptide target
|
GB2401040A
(en)
|
2003-04-28 |
2004-11-03 |
Chugai Pharmaceutical Co Ltd |
Method for treating interleukin-6 related diseases
|
KR100973564B1
(ko)
|
2003-05-02 |
2010-08-03 |
젠코어 인코포레이티드 |
최적화된 Fc 변이체 및 그의 제조 방법
|
US6921978B2
(en)
|
2003-05-08 |
2005-07-26 |
International Business Machines Corporation |
Method to generate porous organic dielectric
|
EP1629010A1
(en)
|
2003-05-30 |
2006-03-01 |
Genentech, Inc. |
Treatment with anti-vegf antibodies
|
WO2005000351A2
(en)
|
2003-06-05 |
2005-01-06 |
Genentech, Inc. |
Combination therapy for b cell disorders
|
US8597911B2
(en)
|
2003-06-11 |
2013-12-03 |
Chugai Seiyaku Kabushiki Kaisha |
Process for producing antibodies
|
JP2005053541A
(ja)
|
2003-08-05 |
2005-03-03 |
Toppan Printing Co Ltd |
紙容器用積層材料及びそれを用いた紙容器
|
US20080008710A1
(en)
|
2003-09-04 |
2008-01-10 |
Hiroyuki Aburatani |
Therapeutic Agent And Diagnostic Agent For Cholangiocarcinoma
|
US7297336B2
(en)
|
2003-09-12 |
2007-11-20 |
Baxter International Inc. |
Factor IXa specific antibodies displaying factor VIIIa like activity
|
WO2005035753A1
(ja)
|
2003-10-10 |
2005-04-21 |
Chugai Seiyaku Kabushiki Kaisha |
機能蛋白質を代替する二重特異性抗体
|
US20080075712A1
(en)
|
2003-10-14 |
2008-03-27 |
Kunihiro Hattori |
Double Specific Antibodies Substituting For Functional Proteins
|
EP2385069A3
(en)
|
2003-11-12 |
2012-05-30 |
Biogen Idec MA Inc. |
Neonatal Fc rReceptor (FcRn)- binding polypeptide variants, dimeric Fc binding proteins and methods related thereto
|
WO2005063815A2
(en)
|
2003-11-12 |
2005-07-14 |
Biogen Idec Ma Inc. |
Fcϝ receptor-binding polypeptide variants and methods related thereto
|
HUE035520T2
(en)
|
2003-12-10 |
2018-05-28 |
Squibb & Sons Llc |
Interferon alpha antibodies and their use
|
AU2004308439A1
(en)
|
2003-12-22 |
2005-07-14 |
Centocor, Inc. |
Methods for generating multimeric molecules
|
US20050266425A1
(en)
|
2003-12-31 |
2005-12-01 |
Vaccinex, Inc. |
Methods for producing and identifying multispecific antibodies
|
NZ548702A
(en)
|
2004-01-09 |
2009-06-26 |
Pfizer |
Antibodies to MAdCAM
|
ITBO20040008U1
(it)
|
2004-02-03 |
2004-05-03 |
Tonazzi S R L |
Macchina per il riempimento e la chiusura di tubetti
|
JP4223981B2
(ja)
|
2004-03-24 |
2009-02-12 |
学校法人東海大学 |
ホルムアルデヒド検知材料およびその製造方法
|
EP1737890A2
(en)
|
2004-03-24 |
2007-01-03 |
Xencor, Inc. |
Immunoglobulin variants outside the fc region
|
WO2005112564A2
(en)
|
2004-04-15 |
2005-12-01 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Germline and sequence variants of humanized antibodies and methods of making and using them
|
EP1742061A4
(en)
|
2004-04-28 |
2007-11-21 |
Perseus Proteomics Inc |
MEDIUM FOR PREDICTING AND EVALUATING THE REACTION OF LIVER CANCER AFTER TREATMENT
|
EA010350B1
(ru)
|
2004-06-03 |
2008-08-29 |
Новиммун С.А. |
Антитела против cd3 и способы их применения
|
WO2005117980A1
(en)
|
2004-06-04 |
2005-12-15 |
Pfizer Products Inc. |
Method for treating abnormal cell growth
|
KR100620554B1
(ko)
|
2004-06-05 |
2006-09-06 |
한국생명공학연구원 |
Tag-72에 대한 인간화 항체
|
AR049390A1
(es)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
EP1773391A4
(en)
|
2004-06-25 |
2009-01-21 |
Medimmune Inc |
INCREASING THE PRODUCTION OF RECOMBINANT ANTIBODIES IN MAMMALIAN CELLS BY MUTAGENESIS ON THE SITE
|
DE102004032634A1
(de)
|
2004-07-06 |
2006-02-16 |
Sms Demag Ag |
Verfahren und Einrichtung zum Messen und Regeln der Planheit und/oder der Bandspannungen eines Edelstahlbandes oder einer Edelstahlfolie beim Kaltwalzen in einem Vielwalzengerüst, insbesondere in einem 20-Walzen-Sendizimir-Walzwerk
|
CN111925445A
(zh)
|
2004-07-09 |
2020-11-13 |
中外制药株式会社 |
抗-磷脂酰肌醇蛋白聚糖3抗体
|
JP4331227B2
(ja)
|
2004-07-09 |
2009-09-16 |
中外製薬株式会社 |
抗グリピカン3抗体
|
EP2940043A1
(en)
|
2004-07-15 |
2015-11-04 |
Xencor, Inc. |
Optimized fc variants
|
CN101001873B
(zh)
|
2004-08-04 |
2013-03-13 |
曼璀克生物科技有限责任公司 |
Fc区变体
|
AU2005277567A1
(en)
|
2004-08-16 |
2006-03-02 |
Medimmune, Llc |
Integrin antagonists with enhanced antibody dependent cell-mediated cytotoxicity activity
|
EP1800693B1
(en)
|
2004-08-24 |
2013-07-17 |
Chugai Seiyaku Kabushiki Kaisha |
Adjuvant therapy with the use of anti-glypican 3 antibody
|
AU2005282700A1
(en)
|
2004-09-02 |
2006-03-16 |
Genentech, Inc. |
Heteromultimeric molecules
|
US7572456B2
(en)
|
2004-09-13 |
2009-08-11 |
Macrogenics, Inc. |
Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereof
|
US20080233131A1
(en)
|
2004-09-14 |
2008-09-25 |
Richard John Stebbings |
Vaccine
|
US20060074225A1
(en)
|
2004-09-14 |
2006-04-06 |
Xencor, Inc. |
Monomeric immunoglobulin Fc domains
|
US7563443B2
(en)
|
2004-09-17 |
2009-07-21 |
Domantis Limited |
Monovalent anti-CD40L antibody polypeptides and compositions thereof
|
RU2451030C2
(ru)
|
2004-10-26 |
2012-05-20 |
Чугаи Сейяку Кабусики Кайся |
Анти-глипикан 3-антитело, имеющее модифицированную сахарную цепь
|
US7462697B2
(en)
|
2004-11-08 |
2008-12-09 |
Epitomics, Inc. |
Methods for antibody engineering
|
EP1838349A1
(en)
|
2004-12-15 |
2007-10-03 |
Neuralab, Ltd. |
Amyloid beta antibodies for use in improving cognition
|
US20090061485A1
(en)
|
2004-12-22 |
2009-03-05 |
Chugai Seiyaku Kabushiki Kaisha |
Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited
|
WO2006074397A2
(en)
|
2005-01-05 |
2006-07-13 |
Biogen Idec Ma Inc. |
Cripto binding molecules
|
WO2006076594A2
(en)
|
2005-01-12 |
2006-07-20 |
Xencor, Inc. |
Antibodies and fc fusion proteins with altered immunogenicity
|
US20060263357A1
(en)
|
2005-05-05 |
2006-11-23 |
Tedder Thomas F |
Anti-CD19 antibody therapy for autoimmune disease
|
CN101171263A
(zh)
|
2005-03-04 |
2008-04-30 |
比奥根艾迪克Ma公司 |
通过合理修饰互补决定区残基使免疫球蛋白可变区人源化的方法
|
US9493569B2
(en)
|
2005-03-31 |
2016-11-15 |
Chugai Seiyaku Kabushiki Kaisha |
Structural isomers of sc(Fv)2
|
ES2592271T3
(es)
|
2005-03-31 |
2016-11-29 |
Chugai Seiyaku Kabushiki Kaisha |
Métodos de producción de polipéptidos mediante la regulación de la asociación de los polipéptidos
|
CA2602663A1
(en)
|
2005-03-31 |
2006-10-05 |
Xencor, Inc. |
Fc variants with optimized properties
|
TW200714313A
(en)
|
2005-04-08 |
2007-04-16 |
Chugai Pharmaceutical Co Ltd |
Antibodies that substitute for coagulation factor VIII
|
EP1908482B1
(en)
|
2005-06-10 |
2017-09-06 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilizer for protein preparation comprising meglumine and use thereof
|
TW200718780A
(en)
|
2005-06-10 |
2007-05-16 |
Chugai Pharmaceutical Co Ltd |
Sc(Fv)2 site-directed mutant
|
JP2009500344A
(ja)
|
2005-07-01 |
2009-01-08 |
メディミューン,エルエルシー |
マルチドメインタンパク質治療薬を製造するための統合的手法
|
JP5072595B2
(ja)
|
2005-08-05 |
2012-11-14 |
中外製薬株式会社 |
マルチキナーゼ阻害剤
|
WO2007024535A2
(en)
|
2005-08-19 |
2007-03-01 |
Wyeth |
Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders
|
WO2007030571A2
(en)
|
2005-09-06 |
2007-03-15 |
Molecular Image Inc. |
Identification of targets and development of reagents for testing and molecular imaging of human disease
|
JP2007093274A
(ja)
|
2005-09-27 |
2007-04-12 |
Perseus Proteomics Inc |
癌の診断方法および治療薬
|
US20070087005A1
(en)
|
2005-10-14 |
2007-04-19 |
Lazar Gregory A |
Anti-glypican-3 antibody
|
EP1954272A2
(en)
|
2005-10-31 |
2008-08-13 |
Bayer Pharmaceuticals Corporation |
Treatment of cancer with sorafenib
|
WO2007059111A2
(en)
|
2005-11-14 |
2007-05-24 |
Entremed, Inc. |
Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
|
WO2007060411A1
(en)
|
2005-11-24 |
2007-05-31 |
Ucb Pharma S.A. |
Anti-tnf alpha antibodies which selectively inhibit tnf alpha signalling through the p55r
|
US10155816B2
(en)
|
2005-11-28 |
2018-12-18 |
Genmab A/S |
Recombinant monovalent antibodies and methods for production thereof
|
US7723043B2
(en)
|
2006-01-04 |
2010-05-25 |
Picobella, Lp |
Methods for screening for prostate cancer
|
CN101415422B
(zh)
|
2006-02-09 |
2012-11-07 |
第一三共株式会社 |
抗癌药用组合物
|
EP1820513A1
(en)
|
2006-02-15 |
2007-08-22 |
Trion Pharma Gmbh |
Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies
|
TW200745163A
(en)
|
2006-02-17 |
2007-12-16 |
Syntonix Pharmaceuticals Inc |
Peptides that block the binding of IgG to FcRn
|
WO2007099988A1
(ja)
|
2006-02-28 |
2007-09-07 |
Kyowa Hakko Kogyo Co., Ltd. |
α-1,6-フコシルトランスフェラーゼ変異体とその用途
|
JP2007256063A
(ja)
|
2006-03-23 |
2007-10-04 |
Seiko Epson Corp |
表示装置、および、電子機器
|
EP1999154B1
(en)
|
2006-03-24 |
2012-10-24 |
Merck Patent GmbH |
Engineered heterodimeric protein domains
|
DK3056568T3
(da)
|
2006-03-31 |
2021-11-01 |
Chugai Pharmaceutical Co Ltd |
Fremgangsmåder til kontrollering af antistoffers blodfarmakokinetik
|
US9670269B2
(en)
|
2006-03-31 |
2017-06-06 |
Chugai Seiyaku Kabushiki Kaisha |
Methods of modifying antibodies for purification of bispecific antibodies
|
WO2007137170A2
(en)
|
2006-05-20 |
2007-11-29 |
Seattle Genetics, Inc. |
Anti-glypican-3 antibody drug conjugates
|
AU2007258694B2
(en)
|
2006-06-06 |
2011-12-22 |
Glaxo Group Limited |
Administration of anti-CD3 antibodies in the treatment of autoimmune diseases
|
EP2047863B1
(en)
|
2006-06-08 |
2013-07-31 |
Chugai Seiyaku Kabushiki Kaisha |
Preventive or remedy for inflammatory disease
|
EP2035456A1
(en)
|
2006-06-22 |
2009-03-18 |
Novo Nordisk A/S |
Production of bispecific antibodies
|
GB2440721A
(en)
|
2006-08-11 |
2008-02-13 |
Univ Cambridge Tech |
Composite biomaterial formed by cooling a fluid composition on a porous solid and removing solidified crystals of the liquid carrier
|
JP4463793B2
(ja)
|
2006-10-10 |
2010-05-19 |
浜松ホトニクス株式会社 |
光検出装置
|
US20100034194A1
(en)
|
2006-10-11 |
2010-02-11 |
Siemens Communications Inc. |
Eliminating unreachable subscribers in voice-over-ip networks
|
WO2008090960A1
(ja)
|
2007-01-24 |
2008-07-31 |
Kyowa Hakko Kirin Co., Ltd. |
ガングリオシドgm2に特異的に結合する遺伝子組換え抗体組成物
|
EP2132312B1
(en)
*
|
2007-03-27 |
2016-01-27 |
Sea Lane Biotechnologies,llc. |
Constructs and libraries comprising antibody surrogate light chain sequences
|
EP2139924B1
(en)
|
2007-03-29 |
2016-07-06 |
Genmab A/S |
Bispecific antibodies and methods for production thereof
|
AU2008255352B2
(en)
|
2007-05-31 |
2014-05-22 |
Genmab A/S |
Stable IgG4 antibodies
|
EP2176294B1
(en)
|
2007-06-29 |
2015-05-20 |
Merck Sharp & Dohme Corp. |
Uses of mdl-1 antagonists
|
RS54624B1
(en)
|
2007-07-17 |
2016-08-31 |
E. R. Squibb & Sons, L.L.C. |
MONOCLONIC ANTIBODIES AGAINST GLIPICAN-3
|
KR101561314B1
(ko)
|
2007-09-26 |
2015-10-16 |
추가이 세이야쿠 가부시키가이샤 |
항il-6 수용체 항체
|
CN101874041B
(zh)
|
2007-09-26 |
2013-06-19 |
中外制药株式会社 |
抗体恒定区修饰体
|
CN101874042B9
(zh)
|
2007-09-26 |
2019-01-01 |
中外制药株式会社 |
利用cdr的氨基酸取代来改变抗体等电点的方法
|
NZ584769A
(en)
|
2007-09-28 |
2011-09-30 |
Chugai Pharmaceutical Co Ltd |
Anti-glypican-3 antibody having improved kinetics in plasma
|
JP5314033B2
(ja)
|
2007-10-22 |
2013-10-16 |
メルク セローノ ソシエテ アノニム |
突然変異IgGFcフラグメントと融合した単一IFN−ベータ
|
US20090162359A1
(en)
|
2007-12-21 |
2009-06-25 |
Christian Klein |
Bivalent, bispecific antibodies
|
US8242247B2
(en)
|
2007-12-21 |
2012-08-14 |
Hoffmann-La Roche Inc. |
Bivalent, bispecific antibodies
|
JP6157046B2
(ja)
|
2008-01-07 |
2017-07-05 |
アムジェン インコーポレイテッド |
静電的ステアリング(electrostaticsteering)効果を用いた抗体Fcヘテロ二量体分子を作製するための方法
|
JP5619603B2
(ja)
|
2008-03-17 |
2014-11-05 |
国立大学法人宮崎大学 |
抗グリピカン3抗体を用いる肝癌細胞の検出法
|
JP5425180B2
(ja)
|
2008-03-27 |
2014-02-26 |
ザイモジェネティクス, インコーポレイテッド |
PDGFRβおよびVEGF−Aを阻害するための組成物および方法
|
CL2009000647A1
(es)
|
2008-04-04 |
2010-06-04 |
Chugai Pharmaceutical Co Ltd |
Composicion farmaceutica para tratar o prevenir cancer hepatico que comprende una combinacion de un agente quimioterapeutico y un anticuerpo anti-glipicano 3; agente para atenuar un efecto secundario que comprende dicho anticuerpo; metodo para tratar o prevenir un cancer hepatico de un sujeto.
|
DK2275443T3
(en)
|
2008-04-11 |
2016-02-08 |
Chugai Pharmaceutical Co Ltd |
Antigen-binding molecule capable of repetitively binding to two or more antigen molecules
|
CN101377506A
(zh)
|
2008-04-16 |
2009-03-04 |
北京科美东雅生物技术有限公司 |
磷脂酰肌醇蛋白聚糖-3化学发光免疫分析测定试剂盒及其制备方法
|
BRPI0910482A2
(pt)
|
2008-04-29 |
2019-09-24 |
Abbott Lab |
imunoglobinas de domínio variável duplo e usos das mesmas
|
WO2009149185A2
(en)
|
2008-06-03 |
2009-12-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
DE102008042377A1
(de)
|
2008-09-25 |
2010-04-01 |
Robert Bosch Gmbh |
Audioverstärker mit Lastanpassung sowie Verfahren zur Lastanpassung des Audioverstärkers
|
KR20110047255A
(ko)
|
2008-09-26 |
2011-05-06 |
로슈 글리카트 아게 |
이중특이적 항-egfr/항-igf-1r 항체
|
TWI440469B
(zh)
|
2008-09-26 |
2014-06-11 |
Chugai Pharmaceutical Co Ltd |
Improved antibody molecules
|
CN102292352A
(zh)
*
|
2008-10-10 |
2011-12-21 |
新兴产品开发西雅图有限公司 |
Tcr复合物免疫治疗剂
|
DE202008016028U1
(de)
|
2008-12-04 |
2010-04-15 |
Melitta Haushaltsprodukte Gmbh & Co. Kg |
Behälter zur Aufbewahrung von Gegenständen
|
CA2750533A1
(en)
|
2009-01-23 |
2010-07-29 |
Biogen Idec Ma Inc. |
Stabilized fc polypeptides with reduced effector function and methods of use
|
SG173705A1
(en)
|
2009-03-05 |
2011-09-29 |
Abbott Lab |
Il-17 binding proteins
|
US20120071634A1
(en)
|
2009-03-19 |
2012-03-22 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody Constant Region Variant
|
US9228017B2
(en)
|
2009-03-19 |
2016-01-05 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody constant region variant
|
EP2233500A1
(en)
|
2009-03-20 |
2010-09-29 |
LFB Biotechnologies |
Optimized Fc variants
|
EP2414399A1
(en)
|
2009-04-01 |
2012-02-08 |
F. Hoffmann-La Roche AG |
Anti-fcrh5 antibodies and immunoconjugates and methods of use
|
JP5616428B2
(ja)
|
2009-04-07 |
2014-10-29 |
ロシュ グリクアート アクチェンゲゼルシャフト |
三価の二重特異性抗体
|
EP3505636A1
(en)
|
2009-04-27 |
2019-07-03 |
OncoMed Pharmaceuticals, Inc. |
Method for making heteromultimeric molecules
|
KR20120027055A
(ko)
|
2009-06-26 |
2012-03-20 |
리제네론 파라마큐티칼스 인코포레이티드 |
천연 면역글로불린 포맷을 가지는 용이하게 분리된 이중특이성 항체
|
CA2771575A1
(en)
|
2009-08-29 |
2011-03-03 |
Abbott Laboratories |
Therapeutic dll4 binding proteins
|
US10053513B2
(en)
|
2009-11-30 |
2018-08-21 |
Janssen Biotech, Inc. |
Antibody Fc mutants with ablated effector functions
|
JP2011118775A
(ja)
|
2009-12-04 |
2011-06-16 |
Sony Corp |
検索装置、検索方法、及び、プログラム
|
ES2777901T3
(es)
|
2009-12-25 |
2020-08-06 |
Chugai Pharmaceutical Co Ltd |
Método de modificación de polipéptidos para purificar multímeros polipeptídicos
|
KR101913440B1
(ko)
|
2010-03-02 |
2018-10-30 |
교와 핫꼬 기린 가부시키가이샤 |
개변 항체 조성물
|
JP5932670B2
(ja)
|
2010-03-11 |
2016-06-08 |
ライナット ニューロサイエンス コーポレイション |
pH依存性の抗原結合を有する抗体
|
TWI667346B
(zh)
|
2010-03-30 |
2019-08-01 |
中外製藥股份有限公司 |
促進抗原消失之具有經修飾的FcRn親和力之抗體
|
US9150663B2
(en)
|
2010-04-20 |
2015-10-06 |
Genmab A/S |
Heterodimeric antibody Fc-containing proteins and methods for production thereof
|
TWI586806B
(zh)
|
2010-04-23 |
2017-06-11 |
建南德克公司 |
異多聚體蛋白質之製造
|
EP2569337A1
(en)
|
2010-05-14 |
2013-03-20 |
Rinat Neuroscience Corp. |
Heterodimeric proteins and methods for producing and purifying them
|
CN103154035B
(zh)
|
2010-05-27 |
2017-05-10 |
根马布股份公司 |
针对her2的单克隆抗体
|
JP2013537416A
(ja)
|
2010-08-13 |
2013-10-03 |
メディミューン リミテッド |
変異型Fc領域を含むモノマーポリペプチド及び使用方法
|
CA2815266C
(en)
|
2010-11-05 |
2023-09-05 |
Zymeworks Inc. |
Stable heterodimeric antibody design with mutations in the fc domain
|
WO2012073985A1
(ja)
|
2010-11-30 |
2012-06-07 |
中外製薬株式会社 |
細胞傷害誘導治療剤
|
CN103492565B
(zh)
|
2011-02-25 |
2021-01-29 |
中外制药株式会社 |
FcγRIIb特异性Fc抗体
|
EP3070104B1
(en)
|
2011-04-19 |
2017-12-27 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Human monoclonal antibodies specific for glypican-3 and use thereof
|
EP3939996A1
(en)
|
2011-09-30 |
2022-01-19 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
|
TW201817745A
(zh)
|
2011-09-30 |
2018-05-16 |
日商中外製藥股份有限公司 |
具有促進抗原清除之FcRn結合域的治療性抗原結合分子
|
CN118290588A
(zh)
|
2011-10-27 |
2024-07-05 |
健玛保 |
异二聚体蛋白的生成
|
KR102168733B1
(ko)
|
2011-10-31 |
2020-10-23 |
추가이 세이야쿠 가부시키가이샤 |
중쇄와 경쇄의 회합이 제어된 항원 결합 분자
|
PL2773671T3
(pl)
|
2011-11-04 |
2022-01-24 |
Zymeworks Inc. |
Projekt stabilnego przeciwciała heterodimerycznego z mutacjami w domenie fc
|
WO2014067011A1
(en)
|
2012-11-02 |
2014-05-08 |
Zymeworks Inc. |
Crystal structures of heterodimeric fc domains
|
CN113527469A
(zh)
|
2012-02-09 |
2021-10-22 |
中外制药株式会社 |
抗体的Fc区变异体
|
GB201203051D0
(en)
|
2012-02-22 |
2012-04-04 |
Ucb Pharma Sa |
Biological products
|
KR20140130455A
(ko)
|
2012-03-02 |
2014-11-10 |
로슈 글리카트 아게 |
Adcc-강화 항체를 사용한 암 치료용 예측 바이오마커
|
MX360110B
(es)
|
2012-04-20 |
2018-10-23 |
Merus Nv |
Metodos y medios para la produccion de moleculas de tipo ig.
|
KR20150004856A
(ko)
*
|
2012-04-20 |
2015-01-13 |
이머전트 프로덕트 디벨롭먼트 시애틀, 엘엘씨 |
Cd3 결합 폴리펩타이드
|
CN104520331B
(zh)
*
|
2012-06-01 |
2018-09-07 |
美国政府(由卫生和人类服务部的部长所代表) |
磷脂酰肌醇蛋白聚糖3的高亲和力单克隆抗体及其用途
|
NZ704771A
(en)
|
2012-08-13 |
2018-02-23 |
Regeneron Pharma |
Anti-pcsk9 antibodies with ph-dependent binding characteristics
|
SG11201502451QA
(en)
*
|
2012-09-27 |
2015-05-28 |
Merus B V |
BISPECIFIC IgG ANTIBODIES AS T CELL ENGAGERS
|
US9714291B2
(en)
|
2012-10-05 |
2017-07-25 |
Kyowa Hakko Kirin Co., Ltd |
Heterodimer protein composition
|
CN103833852A
(zh)
*
|
2012-11-23 |
2014-06-04 |
上海市肿瘤研究所 |
针对磷脂酰肌醇蛋白多糖-3和t细胞抗原的双特异性抗体
|
TWI693073B
(zh)
|
2012-12-21 |
2020-05-11 |
日商中外製藥股份有限公司 |
對gpc3標的治療劑療法為有效之患者投與的gpc3標的治療劑
|
AU2014325063B2
(en)
|
2013-09-27 |
2019-10-31 |
Chugai Seiyaku Kabushiki Kaisha |
Method for producing polypeptide heteromultimer
|
EP3940065A1
(en)
|
2013-09-30 |
2022-01-19 |
Chugai Seiyaku Kabushiki Kaisha |
Method for producing antigen-binding molecule using modified helper phage
|
AU2015244814B2
(en)
|
2014-04-07 |
2020-12-24 |
Chugai Seiyaku Kabushiki Kaisha |
Immunoactivating antigen-binding molecule
|
CN113933504A
(zh)
|
2014-05-08 |
2022-01-14 |
中外制药株式会社 |
对gpc3靶向治疗剂疗法有效的患者施用的gpc3靶向治疗剂
|
AU2015260230A1
(en)
|
2014-05-13 |
2016-11-17 |
Chugai Seiyaku Kabushiki Kaisha |
T cell-redirected antigen-binding molecule for cells having immunosuppression function
|
MA40764A
(fr)
|
2014-09-26 |
2017-08-01 |
Chugai Pharmaceutical Co Ltd |
Agent thérapeutique induisant une cytotoxicité
|
SG10201710322VA
(en)
|
2014-12-19 |
2018-02-27 |
Chugai Pharmaceutical Co Ltd |
Anti-c5 antibodies and methods of use
|
TWI831538B
(zh)
|
2014-12-19 |
2024-02-01 |
日商中外製藥股份有限公司 |
抗肌抑素之抗體、含變異Fc區域之多胜肽及使用方法
|
EA201791754A1
(ru)
|
2015-02-05 |
2019-01-31 |
Чугаи Сейяку Кабусики Кайся |
АНТИТЕЛА, СОДЕРЖАЩИЕ ЗАВИСЯЩИЙ ОТ КОНЦЕНТРАЦИИ ИОНОВ АНТИГЕНСВЯЗЫВАЮЩИЙ ДОМЕН, ВАРИАНТЫ Fc-ОБЛАСТИ, IL-8-СВЯЗЫВАЮЩИЕ АНТИТЕЛА И ИХ ПРИМЕНЕНИЯ
|
WO2016159213A1
(ja)
|
2015-04-01 |
2016-10-06 |
中外製薬株式会社 |
ポリペプチド異種多量体の製造方法
|
KR101834708B1
(ko)
*
|
2016-03-14 |
2018-03-06 |
추가이 세이야쿠 가부시키가이샤 |
암의 치료에 이용하기 위한 세포상해 유도 치료제
|
JP6175590B1
(ja)
|
2016-03-14 |
2017-08-02 |
中外製薬株式会社 |
癌の治療に用いるための細胞傷害誘導治療剤
|